Durability and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women

Exclusion Criteria

• •Subjects will be ineligible for participation in this study if the subject:
• •1. Has had retreatment with EN3835 in the area initially treated during the EN3835-201 study since the completion of study EN3835-202.
• •2. Has had liposuction on the body region treated during the EN3835-201 study since the completion of that study.
• •3. Has had any of the following in the area initially treated during the EN3835-201 study since the completion of that study.
• •1. Injections (eg, mesotherapy); radiofrequency device treatments; laser treatment; or surgery (including subcision and/or powered subcision).
• •2. Any investigational treatment for EFP/cellulite.
• •3. Endermologie® or similar treatments.
• •4. Massage therapy.
• •5. Creams (eg, Celluvera™, TriLastin®).
• •4. Any other condition(s) that, in the Investigator's opinion, might indicate the subject is unsuitable for the study.